Roche wins US approval of more convenient Herceptin

Roche wins US approval of more convenient Herceptin

Source: 
Biopharma Dive
snippet: 

Treatment with subcutaneous Herceptin takes just a few minutes, rather than the sometimes hour and a half needed to administer the breast cancer drug intravenously.